We are live on ! Find out more
ICM

ISZO Capital Management Portfolio holdings

AUM $2M
1-Year Est. Return 35.61%
This Fund
S&P 500
This Quarter Est. Return
+72.26%
1 Year Est. Return
+35.61%
3 Year Est. Return
+68.24%
5 Year Est. Return
+471.73%
10 Year Est. Return
–
AUM
$212M
AUM Growth
+$117M
Cap. Flow
+$59.9M
Cap. Flow %
28.22%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
2
Reduced
3
Closed
1

Top Buys

Rank Stock Value
1
DMTK
DermTech, Inc. Common Stock
DMTK
+$70.5M
2
NTP
Nam Tai Property Inc.
NTP
+$10.6M

Top Sells

Rank Stock Value
1
ATEX icon
Anterix
ATEX
+$12.8M
2
NOTV
Inotiv
NOTV
+$6.94M
3
XPEL icon
XPEL
XPEL
+$945K
4
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
+$494K

Sector Composition

Rank Sector Weight
1 Healthcare 66.74%
2 Real Estate 30.71%
3 Consumer Discretionary 2.54%
4 Communication Services 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DMTK
1
DELISTED
DermTech, Inc. Common Stock
DMTK
$92.6M 43.62%
1,822,394
+1,347,372
+284% +$70.5M
NTP
2
DELISTED
Nam Tai Property Inc.
NTP
$65.2M 30.71%
5,285,419
+1,132,686
+27% +$10.6M
CDMO
3
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$42.8M 20.16%
2,346,961
-29,750
-1% -$494K
NOTV
4
DELISTED
Inotiv
NOTV
$6.27M 2.96%
313,522
-446,493
-59% -$6.94M
XPEL icon
5
XPEL
XPEL
$1.22B
$5.39M 2.54%
103,860
-17,562
-14% -$945K
ATEX icon
6
Anterix
ATEX
$1.81B
– –
-340,699
Closed -$12.8M

Similar funds

LBC
Lawrence B. Cohen $2.06M AUM 34.47% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
SCM
SevenOneSeven Capital Management Lancaster, Pennsylvania $2.17M AUM 8.67% 1-Year Est. Return
LCMP
Linse Capital Management PR San Juan, Puerto Rico $2.31M AUM
GIP
General Industrial Partners London, United Kingdom $2.57M AUM
STC
Sarah T. Connolly $1.11M AUM 24.13% 1-Year Est. Return
GC
Gilfoyle & Co San Francisco, California $671K AUM
DU
Delphia (USA) Toronto, Ontario, Canada $445K AUM 28.82% 1-Year Est. Return

ISZO Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, ISZO Capital Management held 6 positions worth $212M, up 122% from $95.5M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

ISZO Capital Management deployed $59.9M of net new capital in Q1 2021, adding to 2 existing holdings.

By sector, the portfolio is most concentrated in Healthcare at 67% of assets, up from 55% a quarter earlier, followed by Real Estate and Consumer Discretionary.

On the sell side, the largest reduction was Inotiv, an estimated $6.94M trimmed.

  • ISZO Capital Management added most to DermTech, Inc. Common Stock in Q1 2021, an estimated $70.5M increase.
  • ISZO Capital Management's biggest Q1 2021 reduction was Inotiv, cutting an estimated $6.94M.
  • ISZO Capital Management fully exited Anterix in Q1 2021, selling an estimated $12.8M.
  • ISZO Capital Management's ten largest holdings make up 100% of its $212M portfolio in Q1 2021.
  • ISZO Capital Management opened 0 new positions and closed 1 in Q1 2021.
  • ISZO Capital Management's portfolio value rose 122% quarter-over-quarter to $212M.

Based on ISZO Capital Management's 13F filing for Q1 2021, filed 17 May 2021.